An extended course of low-dose azithromycin (multiple brands) may significantly reduce treatment failure in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD) ...
The guideline from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) does not recommend antibiotics for prevention of COPD exacerbations. Citing decades-old data on the lack of ...
May 24, 2011 (Denver, Colorado) — The addition of daily azithromycin to conventional treatment for chronic obstructive pulmonary disease (COPD) significantly helps reduce acute exacerbations ...
BOS may be the result of immunologic injury targeting both endothelial and epithelial tissues in the pulmonary system, and such immunologic damage may represent cGVHD, or can be induced and aggravated ...
Adults with active COPD starting azithromycin vs. roflumilast had a decreased risk for first moderate or severe COPD ...
Common side effects of azithromycin (Zithromax) tablets include nausea, vomiting, and abdominal pain. Azithromycin is usually prescribed as a short-term treatment, and most side effects are expected ...
Bronchiolitis obliterans syndrome (BOS), defined as new fixed airflow obstruction that develops in the setting of active chronic GVHD (cGVHD), is a serious and ...
Azithromycin (Zithromax) tablets commonly cause gastrointestinal side effects, like diarrhea, nausea, and abdominal pain. As a short-term antibiotic, most of azithromycin’s side effects are temporary ...
Pilot studies suggest that a single, 2-g oral dose of azithromycin may be an alternative to a 2.4-MU intramuscular dose of penicillin G benzathine in the prevention and treatment of syphilis. We ...
Depending on its form, Medicare Part D or Original Medicare may cover azithromycin. People enrolled in Part C will get the same coverage. Azithromycin (Zithromax) is an antibiotic that doctors often ...
Azithromycin was effective for the treatment for women with Ureaplasma urealyticum, showing a similar therapeutic effect to that of doxycycline. Results of a systematic review and meta-analysis ...
Mass distribution of azithromycin to children 1 to 59 months of age has been shown to reduce childhood all-cause mortality in some sub-Saharan African regions, with the largest reduction seen among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results